Alector (ALEC) Return on Capital Employed (2019 - 2026)
Alector (ALEC) reported Return on Capital Employed of 4.52% for Q1 2026, up 3991.0% year-over-year from 0.11% in Q1 2025, and up 63.08% quarter-over-quarter from 12.25% in Q4 2025.
Alector (ALEC) Return on Capital Employed (2019 - 2026) Analysis & Trends
Alector (ALEC) has 8 years of Return on Capital Employed data on file, last reported at 4.52% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 4.52%, up 3991.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.52% (up 3991.0% YoY), and the FY2025 annual result was 9.63%, up 2489.0% from the prior year.
- Return on Capital Employed improved to 4.52% in Q1 2026 per ALEC's latest filing, from 12.25% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 8.5% in Q2 2022 and troughed at 46.52% in Q3 2025.
- A 5-year average of 19.67% and a median of 15.43% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed plunged 4017 bps in 2025, then soared 3991 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 19.18% in 2022, then surged by 71 bps to 5.58% in 2023, then plunged by 608 bps to 39.5% in 2024, then soared by 69 bps to 12.25% in 2025, then jumped by 63 bps to 4.52% in 2026.
- Business Quant data shows ALEC's Return on Capital Employed at 4.52% in Q1 2026, 12.25% in Q4 2025, and 46.52% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -4.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.52% |
| Dec 31, 2025 | -12.25% |
| Sep 30, 2025 | -46.52% |
| Jun 30, 2025 | -45.14% |
| Mar 31, 2025 | -44.44% |
| Dec 31, 2024 | -39.50% |
| Sep 30, 2024 | -14.88% |
| Jun 30, 2024 | -13.57% |
| Mar 31, 2024 | -4.27% |
| Dec 31, 2023 | -5.58% |
| Sep 30, 2023 | -29.85% |
| Jun 30, 2023 | -26.31% |
| Mar 31, 2023 | -21.51% |
| Dec 31, 2022 | -19.18% |
| Sep 30, 2022 | -15.43% |
| Jun 30, 2022 | 8.50% |
| Mar 31, 2022 | 0.12% |
| Dec 31, 2021 | -1.10% |
| Sep 30, 2021 | 24.52% |
| Jun 30, 2021 | -17.20% |